Stephen Aselage

Président chez Acuitas Therapeutics, Inc.

Profil

Stephen J.
Aselage currently works at Acuitas Therapeutics, Inc., as Chairman and Patara Pharma LLC, as Director.
Mr. Aselage also formerly worked at Retrophin LLC, as Chief Executive Officer & Director from 2012 to 2013, Kyalin Biosciences, Inc., as Chief Executive Officer, Acer Therapeutics, Inc., as Chairman, Desert Gateway, Inc., as Chairman from 2012 to 2013, Acer Therapeutics, Inc., as Chairman from 2017 to 2023, Advanced Tissue Sciences, Inc., as Director-Sales & Marketing from 1996 to 1999, APT Pharmaceuticals, Inc., as Director, BioCryst Pharmaceuticals, Inc., as Independent Director from 2019 to 2025, Opexa Therapeutics, Inc., as Director, Travere Therapeutics, Inc., as Director from 2019 to 2022, National Pku Alliance, as Director, Genentech, Inc., as Sales Manager from 1986 to 1993, SangStat Medical Corp., as Senior VP-North American Sales & Marketing in 2004, CTI BioPharma Corp., as Executive VP-Global Commercial Operations in 2005, BioMarin Pharmaceutical, Inc., as Chief Business Officer & Executive Vice President from 2009 to 2012, Genzyme Corp., as Senior VP-North American Sales & Marketing in 2004, and Rorer Pharmaceuticals, Inc., as Sales Manager.
Mr. Aselage received his undergraduate degree in 1973 from the University of Notre Dame.

Postes actifs de Stephen Aselage

Sociétés	Poste	Début
Patara Pharma LLC	Directeur/Membre du Conseil	-
Acuitas Therapeutics, Inc.	Président	-

Anciens postes connus de Stephen Aselage

Sociétés	Poste	Fin
BIOCRYST PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	12/06/2025
ACER THERAPEUTICS INC.	Président	17/11/2023
TRAVERE THERAPEUTICS, INC.	Directeur Général	04/01/2019
Retrophin LLC	President	21/02/2013
Desert Gateway, Inc.	Président	21/02/2013